Fifth Third Bancorp’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223 Sell
269
-45
-14% -$41 ﹤0.01% 4284
2026
Q1
$386 Buy
314
+222
+241% +$386 ﹤0.01% 4201
2025
Q4
$264 Hold
92
﹤0.01% 2583
2025
Q3
$374 Sell
92
-53
-37% -$212 ﹤0.01% 2604
2025
Q2
$566 Buy
+145
New +$457 ﹤0.01% 2477
2024
Q2
Sell
-4,936
Closed -$39.8K 2462
2024
Q1
$39.8K Buy
4,936
+210
+4% +$1.86K ﹤0.01% 1435
2023
Q4
$47K Hold
4,726
﹤0.01% 1412
2023
Q3
$37.8K Hold
4,726
﹤0.01% 1468
2023
Q2
$52K Buy
4,726
+448
+10% +$4.61K ﹤0.01% 1342
2023
Q1
$44.2K Buy
4,278
+551
+15% +$6.49K ﹤0.01% 1482
2022
Q4
$41K Buy
3,727
+734
+25% +$9.44K ﹤0.01% 1415
2022
Q3
$47K Buy
2,993
+13
+0.4% +$286 ﹤0.01% 1336
2022
Q2
$68K Buy
2,980
+1,795
+151% +$38.4K ﹤0.01% 1250
2022
Q1
$29K Buy
1,185
+521
+78% +$11.8K ﹤0.01% 1669
2021
Q4
$18K Buy
+664
New +$23.2K ﹤0.01% 1889

Other funds holding DH

Fifth Third Bancorp's DH Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Definitive Healthcare (DH) stake by 14% in Q2 2026, selling an estimated $41 and leaving 269 shares worth $223. The position accounts for ﹤0.01% of the portfolio, ranked #4284.

Fifth Third Bancorp first reported a position in DH in Q4 2021 and has held it in 15 quarters since. The position peaked at $68K in Q2 2022. 21 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Fifth Third Bancorp held 269 shares of Definitive Healthcare worth $223 as of Q2 2026.
  • Fifth Third Bancorp sold 45 Definitive Healthcare shares in Q2 2026, an estimated $41.
  • Definitive Healthcare made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4284 holding.
  • Fifth Third Bancorp first reported a position in Definitive Healthcare in Q4 2021 and has held it in 15 quarters since.
  • Fifth Third Bancorp's Definitive Healthcare position peaked at $68K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.